New data links MASLD to higher androgenetic alopecia risk, especially in women. Explore how lifestyle factors intensify this ...

Absci Corporation stock jumps after initiating dosing in its phase I/IIa ABS-201 study for androgenetic alopecia, seeking early safety and efficacy signals.

Study to evaluate safety and efficacy of novel anti-PRLR antibody; interim data anticipated in the second half of 2026Trial design leverages ...

PCOS prevalence varies globally with higher rates observed among Indian women compared to other populations characterized by ...

Partnership aims to destigmatize androgenetic alopecia and highlight the need for new therapeutic options that address the root cause of disease Donovan to share his personal journey at Absci’s ...

This article was reviewed by Sara Harcharik Perkins, MD. Spironolactone for Hair Loss: Benefits, Dosage, and Risks Key ...

An acne drug, clascoterone, has demonstrated remarkable results in treating male pattern baldness. In two large Phase III ...

Potential side effects of using minoxidil should be considered before taking this medication. Using the oral form of the ...

Hair transplants are the only cosmetic procedure where male patients significantly outnumber females, but the number of women opting to treat their hair loss through surgery is rising.

“This results in more effective and more rapid growth of the hair within each hair follicle,” Weiser said. “Additionally, LED ...

Inhibiting prolactin receptor (PRLR) signaling with the ABS-201 anti-PRLR antibody promotes human hair follicle growth ex vivo ...